Friday 5 from Practical Cardiology - May 14

The Friday 5 from Practical Cardiology is a list composed by the Practical Cardiology editorial staff aimed at highlighting relevant coverage of news in cardiovascular medicine.

Every Friday, Practical Cardiology provides a curated list of 5 articles focused or related to a particular topic. This week, the Friday 5 from Practical Cardiology highlights the latest edition of Inside Cardiology, which features a 5-part panel discussion with Practical Cardiology Editorial Advisory Board members Guy Mintz, MD, Lucia Novak, CRNP, and Brett Nowlan, MD.

1. AHA Provides Overview of CV Risk Associated with Hormone Therapies Used in Breast, Prostate Cancer Treatment

The AHA has released a scientific statement aimed at outlining the current knowledge base related to risk of cardiovascular disease associated with hormonal therapies used in the treatment of breast and prostate cancer.

2. AHA/ASA Release Guidance for Treatment of COVID-19 Vaccine-Related Clotting, Low Platelet Counts

The American Heart Association and American Stroke Association have released a special report related to the treatment of blood clots or low platelet counts related to the COVID-19 vaccine, which has garnered mass amounts of attention despite being a rare complication.

3. Bariatric Surgery Linked to Lower Risk of Cardiovascular Death, Adverse Events in Patients with T2D

An analysis of claims data from more than 7k patients suggests patients with severe obesity and type 2 diabetes who underwent bariatric surgery experienced a 68% reduction in cardiac mortality and 34% reduction in cardiac events compared against standard medical management.

4. Comparing Days Alive and Out of Hospital with Invasive vs Conservative Management in ISCHEMIA

New data from an analysis of the ISCHEMIA trial is providing insight into the days alive out of hospital with an initial invasive or conservative approach to the management of stable ischemic heart disease.

5. Do N-of-1 Studies Prove Statin Muscle Complaints are Bogus?

Dr. Paul Thompson reflects on the results of recent N-of-1 studies examining the effects of statin therapy on muscle pain and offers his perspective on the conclusions drawn by these trials.